Cardioprotective effect of metoprolol and enalapril in doxorubicin-treated lymphoma patients: A prospective, parallel-group, randomized, controlled study with 36-month follow-up-Reference-Cited by-同舟云学术

Cardioprotective effect of metoprolol and enalapril in doxorubicin-treated lymphoma patients: A prospective, parallel-group, randomized, controlled study with 36-month follow-up

Published:2010-10-25 Issue:11 Volume:85 Page:894-896
ISSN:0361-8609
Container-title:American Journal of Hematology
language:en
Short-container-title:Am. J. Hematol.

Author:

Georgakopoulos Peter,Roussou Paraskevi,Matsakas Evangellos,Karavidas Apostolos,Anagnostopoulos Nick,Marinakis Theodoros,Galanopoulos Athanasios,Georgiakodis Fotis,Zimeras Stelios,Kyriakidis Michael,Ahimastos Apostolos

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/ajh.21840/fullpdf

Cited by 177 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cardioprotection Using Doxorubicin: The Role of Dexrazoxane;Pharmaceutical Science;2024-07-10

2. Research progress on the role and mechanism of Sirtuin family in doxorubicin cardiotoxicity;Phytomedicine;2024-07

3. A prospective randomized controlled trial to determine the safety and efficacy of extracorporeal shock waves therapy for primary prevention of subclinical cardiotoxicity in breast cancer patients without a cardiovascular risk treated with doxorubicin;Frontiers in Cardiovascular Medicine;2024-02-07

4. Ivabradine for the Prevention of Anthracycline-Induced Cardiotoxicity in Female Patients with Primarily Breast Cancer: A Prospective, Randomized, Open-Label Clinical Trial;Medicina;2023-12-09

5. Heartbreaker: Detection and prevention of cardiotoxicity in hematological malignancies;Blood Reviews;2023-12